UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056085
Receipt number R000064087
Scientific Title Exploratory study on the effects of short-chain aldehydes on liver tissue
Date of disclosure of the study information 2024/11/07
Last modified on 2024/11/07 13:38:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study on the effects of short-chain aldehydes on liver tissue

Acronym

Exploratory study on the effects of short-chain aldehydes on liver tissue

Scientific Title

Exploratory study on the effects of short-chain aldehydes on liver tissue

Scientific Title:Acronym

Exploratory study on the effects of short-chain aldehydes on liver tissue

Region

Japan


Condition

Condition

Liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Explore the effects of short-chain aldehydes on liver tissue

Basic objectives2

Others

Basic objectives -Others

Elucidate the impact of glyceraldehyde, produced in the metabolic pathways of glucose and fructose, on the pathogenesis of MASLD

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

plasma glyceraldehyde

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Individuals aged 18 and older hospitalized for scheduled liver resection

Key exclusion criteria

Individuals diagnosed with hepatitis B or hepatitis C.
Individuals taking oral steroid medications.
Individuals scheduled for liver transplantation.





Target sample size

35


Research contact person

Name of lead principal investigator

1st name Kaori
Middle name
Last name Ikeda

Organization

Kyoto University Hospital

Division name

Institute for Advancement of Clinical and Translational Science/Department of Diabetes, Endocrinology and Nutrition

Zip code

606-8501

Address

54 Shogoinkawahara-cho, Sakyo-ku,Kyoto-shi,Kyoto

TEL

0757513560

Email

krikeda@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Yoko
Middle name
Last name Ueba

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Diabetes, Endocrinology and Nutrition

Zip code

606-8501

Address

54 Shogoinkawahara-cho, Sakyo-ku,Kyoto-shi,Kyoto

TEL

0757513560

Homepage URL


Email

yokoueba@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Hospital

Institute

Department

Personal name

Kaori Ikeda


Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kyoto Katsura Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

Tel

0757534680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院(京都府)、京都桂病院(京都府)


Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 10 Month 04 Day

Date of IRB

2024 Year 10 Month 25 Day

Anticipated trial start date

2024 Year 11 Month 11 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Evaluate the relationship between liver fat content and the levels of short-chain aldehydes in blood and liver tissue.


Management information

Registered date

2024 Year 11 Month 07 Day

Last modified on

2024 Year 11 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064087